-
Uncategorized6 days ago
Text Mining Culture Conditions and Glycosylation Relationships
A novel data gathering approach that relies on “text mining” can help process developers better understand the complex relationships between culture conditions and glycosylation, say the...
-
Uncategorized6 days agoEli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Eli Lilly’s obesity pill was approved by the Food and Drug Administration on Wednesday, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill...
-
Uncategorized6 days ago
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
-
Uncategorized6 days ago
How a 20-year old asthma drug is boosting food allergy research
How a 20-year old asthma drug is boosting food allergy research
-
Uncategorized6 days ago
Can AI Agents Automate Scientific Discovery?
Nvidia CEO Jensen Huang asserts that agentic AI systems are driving innovation across industries. At his annual NVIDIA GTC keynote, Huang highlighted OpenClaw, the personal AI...
-
Uncategorized6 days agoSTAT+: Insilico Medicine CEO on how best to use AI in drug development
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
Uncategorized6 days ago
11 Startups Selected for National Life Sciences Accelerator Program
Of the 11 companies participating in the spring cohorts of the Drive program run by MassBio and SCbio, eight have locations in Massachusetts. One cohort focuses...
-
Uncategorized6 days ago
Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug program. But for Valneva CEO...
-
Uncategorized6 days agoSTAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’re officially in...
-
Uncategorized6 days ago
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
BioNTech to shutter Singapore HQ after ‘comprehensive review’
STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
